Author Archives: admin


Platelet-Rich Plasma (PRP) Injections | Johns Hopkins Medicine

Featured Expert:

Platelet-rich plasma (PRP) injections are gaining popularity for a variety of conditions, from sports injuries to hair loss. The treatment uses a patients own blood cells to accelerate healing in a specific area.

Platelet-rich plasma consists of two elements: plasma, or the liquid portion of blood, and platelets, a type of blood cell that plays an important role in healing throughout the body. Platelets are well-known for their clotting abilities, but they also contain growth factors that can trigger cell reproduction and stimulate tissue regeneration or healing in the treated area. Platelet-rich plasma is simply blood that contains more platelets than normal.

To create platelet-rich plasma, clinicians take a blood sample from the patient and place it into a device called a centrifuge that rapidly spins the sample, separating out the other components of the blood from the platelets and concentrating them within the plasma.

After creating platelet-rich plasma from a patients blood sample, that solution is injected into the target area, such as an injured knee or a tendon. In some cases, the clinician may use ultrasound to guide the injection. The idea is to increase the concentration of specific bioproteins or hormones, called growth factors, in a specific area to accelerate the healing process.

The mechanism behind PRP injections is not completely understood. Studies show that the increased concentration of growth factors in platelet-rich plasma may stimulate or speed up the healing process, shortening healing time for injuries, decreasing pain and even encouraging hair growth.

PRP injections are used for a range of conditions,* from musculoskeletal pain and injuries to cosmetic procedures.

PRP injections may be able to treat a range of musculoskeletal injuries and conditions. For example, chronic tendon injuries such as tennis elbowor jumpers kneecan often take a long time to heal, so adding PRP shots to a treatment regimen can help to stimulate the healing process, decrease pain and enable a return to activities sooner.

Clinicians first used PRP to accelerate healing after jaw or plastic surgeries. Now, post-surgical PRP injections have expanded to help heal muscles, tendons and ligaments, as procedures on these tissues have notoriously long recovery times.

Early studies indicate that PRP injections may help treat osteoarthritis pain and stiffness by modulating the joint environment and reducing inflammation, but research is growing.

Our team of experts at the Johns Hopkins Musculoskeletal Center offers platelet-rich plasma injections to help alleviate pain, improve mobility and decrease inflammation.

PRP injections can be effective in treating male pattern baldness, both in preventing hair loss and promoting new hair growth. PRP can also aid in the stimulation of hair growth after hair transplants.

PRP injections are sometimes used as an anti-aging treatment, but there is little evidence to show that PRP reduces wrinkles and other signs of aging.

A PRP injection is a low-risk procedure and does not usually cause major side effects. The procedure involves a blood draw, so you should make sure you are hydrated and have eaten beforehand to prevent feeling lightheaded. After the procedure, you may experience some soreness and bruising at the injection site.

Because PRP injections are made up of your own cells and plasma, the risk of an allergic reaction is much lower than with other injectable medications like corticosteroids. Less common risks of PRP injections include:

If you are considering PRP injections, be sure to talk with your health care provider about all the benefits and risks.

*Research for the different applications of PRP is promising and rapidly growing. Although the equipment used to produce PRP and the injections themselves have been cleared by the FDA, this procedure is considered investigational and has not been officially approved by the FDA for most uses. Since PRP is a substance derived from ones own blood, it is not considered a drug. FDA clearance means that doctors can prescribe and administer PRP if they believe its in the best interest of the patient. However, lack of the FDA approval means that PRP treatments may not be covered by insurance.

Originally posted here:
Platelet-Rich Plasma (PRP) Injections | Johns Hopkins Medicine

Broncos Already Have A Week 6 Russell Wilson Update – Yardbarker

The Denver Broncos are among the more disappointing teams through Week 5 of the 2022 NFL season.

After hiring Nathaniel Hackett as head coach and trading for All-Pro quarterback Russell Wilson, there were high hopes for this team.

Football experts thought their additions would help the talented but underperforming Broncos offense.

Meanwhile, their fans were thrilled about Wilson completing touchdown passes to Jerry Jeudy, Courtland Sutton, and K.J. Hamler.

If that approach didnt work, the Broncos still had Javonte Williams and Melvin Gordon III from the backfield.

Unfortunately, the narrative did not unfold that way, as the Broncos have a losing record after five games.

They struggled to score or move the ball even before Williams suffered a season-ending injury.

However, Wilsons shoulder injury may explain his depressing start.

He has a torn lat in his throwing shoulder which is concerning for their prospects throughout the season.

But despite his condition, Wilson will still suit up for the Broncos in Week 6.

Read more:
Broncos Already Have A Week 6 Russell Wilson Update - Yardbarker

COMPASS Pathways to Hold Virtual Capital Market Day on 12 October 2022

LONDON, Oct. 04, 2022 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today the agenda for its virtual Capital Markets Day on 12 October 2022 at 8:00 am ET (1 pm UK).

Read the rest here:
COMPASS Pathways to Hold Virtual Capital Market Day on 12 October 2022

Castellum, Inc. Announces Intent to Uplist to NYSE American Exchange

POTOMAC, Md., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Castellum, Inc. (“Castellum”) (OTC: ONOV), a cybersecurity, electronic warfare, and IT services company, announced today that, subject to meeting all requirements (including the price requirement) at the time of listing, the Company’s application to list its shares of common stock (the “Common Stock”), has been approved to uplist to the NYSE American Exchange in conjunction with an underwritten public offering and a one-for-twenty reverse stock split of the Common Stock effective on or about October 7, 2022. The ticker symbol for the Common Stock will change to “CTM” upon listing. Trading of the Common Stock is expected to commence on or about October 7, 2022. The new CUSIP for the Common Stock following the reverse stock split will be 14838T204.

More:
Castellum, Inc. Announces Intent to Uplist to NYSE American Exchange

Correction: Dark Horse Consulting Group Welcomes Growth Investment from WestView Capital Partners

Walnut Creek, CA; Boston, MA, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Dark Horse Consulting Group ("DHC"), the leading global consultancy to the cell and gene therapy (“CGT”) industry, and WestView Capital Partners (“WestView”), a Boston-based growth equity firm, are pleased to jointly announce that WestView has completed a growth investment in DHC.

Here is the original post:
Correction: Dark Horse Consulting Group Welcomes Growth Investment from WestView Capital Partners

Psycheceutical Bioscience, Inc.’s Zappy Zapolin Added to The Benzinga Psychedelics Advisory Council

Chief Visionary Officer of Psycheceutical, Zappy Zapolin, will join other prominent leaders in Psychedelics on Benzinga’s Council Board Chief Visionary Officer of Psycheceutical, Zappy Zapolin, will join other prominent leaders in Psychedelics on Benzinga’s Council Board

Follow this link:
Psycheceutical Bioscience, Inc.'s Zappy Zapolin Added to The Benzinga Psychedelics Advisory Council